Dxcover

Developer of a liquid biopsy-based cancer diagnostics platform designed for the early detection of multiple cancer types. The company's platform combines infrared spectroscopy with multi-omic data analysis and machine learning algorithms to analyze blood samples, detect spectral signatures associated with disease, generate rapid diagnostic outputs without complex sample preparation, support high-throughput screening and triage of high-risk populations, integrate clinical data for improved predictive accuracy, and enable scalable deployment across healthcare settings, enabling clinicians, healthcare providers, and research institutions to identify cancers at earlier stages and improve diagnostic efficiency and patient outcomes.